Pregabalin abuse has become an emerging concern; thus, the current study has been designed to study the neurotoxic hazards of prolonged high-dose of pregabalin (akin to that abused by addicts) and to evaluate the effect of alpha tocopherol as a possible ameliorating agent. The current study evaluated the brain neurotransmitters; dopamine, glutamate, and norepinephrine.
The study also assessed the expression of the apoptosis-related markers Bax, Bcl2, and caspase 3. Western-blotted analysis of the three major mitogen-activated protein kinases (MAPKs), the c-JUN N-terminal kinase (JNK), the p38 MAPK, and the extracellular signal-regulated kinase (ERK), has also been performed.
The study also evaluated oxidative stress via assessment of the cortical tissue levels of reduced glutathione and malondialdehyde and the activity of superoxide dismutase. Histopathological examination and histomorphometric evaluation of the darkly degenerated cortical neurons have also been performed. Pregabalin in high doses (150 mg/kg/day and 300 mg/kg/day) disrupted the ERK/JNK/p38-MAPK signaling, reversed the bax/bcl2 ratio, and induced oxidative stress.
AURION R-Gent SE-EM |
|||
| 500.044 | Aurion | 90 mL | Ask for price |
AURION R-Gent SE-Intense |
|||
| 500.066 | Aurion | 60 mL | Ask for price |
AURION R-Gent SE-Intense |
|||
| 500.077 | Aurion | 500 mL | Ask for price |
AURION R-Gent SE-LM, replaced see 500.066 |
|||
| 500.011 | Aurion | 60 mL | Ask for price |
AURION R-Gent SE-LM, replaced see 500.077 |
|||
| 500.022 | Aurion | 500 mL | Ask for price |
LN-319 |
|||
| ABC-TC499S | AcceGen | 1 vial | Ask for price |
|
Description: Tissue: Brain. Tumorigenic. |
|||
AMG-319 |
|||
| 204310 | MedKoo Biosciences | 10.0mg | EUR 190 |
(±)-SLV 319 |
|||
| B7689-10 | ApexBio | 10 mg | EUR 224.8 |
|
Description: GPCR/G protein|Cannabinoid Receptor |
|||
(±)-SLV 319 |
|||
| B7689-25 | ApexBio | 25mg | EUR 476 |
|
Description: GPCR/G protein|Cannabinoid Receptor |
|||
(±)-SLV 319 |
|||
| B7689-5 | ApexBio | 5 mg | EUR 131.2 |
|
Description: GPCR/G protein|Cannabinoid Receptor |
|||
(±)-SLV 319 |
|||
| B7689-50 | ApexBio | 50 mg | EUR 860 |
|
Description: GPCR/G protein|Cannabinoid Receptor |
|||
AMG-319 |
|||
| MBS130665-100mg | MyBiosource | 100mg | EUR 1065 |
AMG-319 |
|||
| MBS130665-500mg | MyBiosource | 500mg | EUR 2775 |
(+/-)-SLV 319 |
|||
| MBS133499-INQUIRE | MyBiosource | INQUIRE | Ask for price |
LabMol-319 |
|||
| HY-150234 | MedChemExpress | 10 mg | EUR 270.57 |
|
Description: LabMol-319 is a potent zika virus (ZIKV) NS5 RdRp inhibitor with an IC50 of 1.6 μM. LabMol-319 is an antiviral agent[1]. |
|||
ACP-319 |
|||
| MBS5779248-INQUIRE | MyBiosource | INQUIRE | Ask for price |
ACP-319 |
|||
| T29615-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: ACP-319 |
|||
ACP-319 |
|||
| T29615-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: ACP-319 |
|||
ACP-319 |
|||
| T29615-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: ACP-319 |
|||
ACP-319 |
|||
| T29615-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: ACP-319 |
|||
ACP-319 |
|||
| T29615-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: ACP-319 |
|||
MEF2A (Ab-319) |
|||
| ANTY021040 | Antagene | 100ug | EUR 259 |
FKHR (Ab-319) |
|||
| ANTY021161 | Antagene | 100ug | EUR 259 |
(S)-SLV 319 |
|||
| C3568-1 | ApexBio | 1 mg | EUR 88.8 |
|
Description: GPCR/G protein|Cannabinoid Receptor |
|||
(S)-SLV 319 |
|||
| C3568-10 | ApexBio | 10 mg | EUR 544 |
|
Description: GPCR/G protein|Cannabinoid Receptor |
|||
(S)-SLV 319 |
|||
| C3568-5 | ApexBio | 5 mg | EUR 347.2 |
|
Description: GPCR/G protein|Cannabinoid Receptor |
|||
(R)-SLV 319 |
|||
| C5122-1 | ApexBio | 1mg | EUR 92 |
|
Description: GPCR/G protein|Cannabinoid Receptor |
|||
(R)-SLV 319 |
|||
| C5122-10 | ApexBio | 10 mg | EUR 524 |
|
Description: GPCR/G protein|Cannabinoid Receptor |
|||
(R)-SLV 319 |
|||
| C5122-5 | ApexBio | 5 mg | EUR 348 |
|
Description: GPCR/G protein|Cannabinoid Receptor |
|||
(R)-SLV 319 |
|||
| C5122-50 | ApexBio | 50 mg | EUR 1490 |
|
Description: CB1 receptor antagonist |
|||
LN-319 cells |
|||
| C0005001 | Addexbio | One Frozen vial | EUR 620 |
IN-KT 319 |
|||
| I627990 | Toronto Research Chemicals | 100mg | EUR 9200 |
|
Description: 1374790-37-0 |
|||
(R)-SLV 319 |
|||
| HY-121616 | MedChemExpress | 5mg | EUR 805.21 |
|
Description: (R)-SLV 319 is a potent and selective cannabinoid receptor 1 (CB1) antagonist with a Ki value of 894 nM. (R)-SLV 319 is a dextrorotatory counterpart of SLV 319[1] |
|||
LN-319 Cells |
|||
| LN001 | Neuromics | each | EUR 1069.2 |
(S)-SLV 319 |
|||
| S560015 | Toronto Research Chemicals | 50mg | EUR 9200 |
|
Description: 464213-10-3 |
|||
(S)-SLV 319 |
|||
| T21914-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: (S)-SLV 319 |
|||
(S)-SLV 319 |
|||
| T21914-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: (S)-SLV 319 |
|||
(S)-SLV 319 |
|||
| T21914-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: (S)-SLV 319 |
|||
(S)-SLV 319 |
|||
| T21914-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: (S)-SLV 319 |
|||
(S)-SLV 319 |
|||
| T21914-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: (S)-SLV 319 |
|||
(R)-SLV 319 |
|||
| T22140-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: (R)-SLV 319 |
|||
(R)-SLV 319 |
|||
| T22140-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: (R)-SLV 319 |
|||
(R)-SLV 319 |
|||
| T22140-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: (R)-SLV 319 |
|||
(R)-SLV 319 |
|||
| T22140-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: (R)-SLV 319 |
|||
(R)-SLV 319 |
|||
| T22140-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: (R)-SLV 319 |
|||
(S)-SLV 319 |
|||
| TRC-S560015-50MG | Toronto Research Chemicals | 50 mg | Ask for price |
IN-KT 319 |
|||
| TRC-I627990-100MG | Toronto Research Chemicals | 100 mg | Ask for price |
LN-319 Cells |
|||
| 116213 | Antibody Research Corporation | 1 Vial | Ask for price |
LN-319 Cells |
|||
| 116213L | Antibody Research Corporation | 0.5 mg | Ask for price |
LN-319 Cells |
|||
| 116213R | Antibody Research Corporation | 100 µg | Ask for price |
FKHR (Ab-319) Antibody |
|||
| 8B7086 | AAT Bioquest | 50ug | EUR 368 |
|
Description: FKHR (Ab-319) Antibody |
|||
MEF2A (Ab-319) Antibody |
|||
| 8B7145 | AAT Bioquest | 50ug | EUR 368 |
|
Description: MEF2A (Ab-319) Antibody |
|||
Influenza HA (307 - 319) |
|||
| 5-01389 | CHI Scientific | 4 x 5mg | EUR 294.84 |
|
Description: Pro-Lys-Tyr-Val-Lys-Gln-Asn-Thr-Leu-Lys-Leu-Ala-Thr |
|||
MEF2A (Ab-319) Antibody |
|||
| 21040 | SAB | 100ul | EUR 319 |
MEF2A (Ab-319) Antibody |
|||
| 21040-100ul | SAB | 100ul | EUR 302.4 |
MEF2A (Ab-319) Antibody |
|||
| 21040-50ul | SAB | 50ul | EUR 224.4 |
FKHR (Ab-319) Antibody |
|||
| 21161 | SAB | 100ul | EUR 319 |
FKHR (Ab-319) Antibody |
|||
| 21161-100ul | SAB | 100ul | EUR 302.4 |
FKHR (Ab-319) Antibody |
|||
| 21161-50ul | SAB | 50ul | EUR 224.4 |
MEF2A (Ab-319) Antibody |
|||
| CSB-PA280396- | Cusabio | each | EUR 402 |
|
Description: A polyclonal antibody against MEF2A (Ab-319). Recognizes MEF2A (Ab-319) from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;IHC:1:50-1:100 |
|||
MEF2A (Ab-319) Antibody |
|||
| CSB-PA280396-100ul | Cusabio | 100ul | EUR 379.2 |
|
Description: A polyclonal antibody against MEF2A (Ab-319). Recognizes MEF2A (Ab-319) from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;IHC:1:50-1:100 |
|||
Zap-70 (Ab-319) |
|||
| ANTY021173 | Antagene | 100ug | EUR 259 |
ZAP70 (Ab-319) Antibody |
|||
| CSB-PA181899- | Cusabio | each | EUR 402 |
|
Description: A polyclonal antibody against ZAP70 (Ab-319). Recognizes ZAP70 (Ab-319) from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;WB:1:500-1:1000, IHC:1:50-1:200 |
|||
ZAP70 (Ab-319) Antibody |
|||
| CSB-PA181899-100ul | Cusabio | 100ul | EUR 379.2 |
|
Description: A polyclonal antibody against ZAP70 (Ab-319). Recognizes ZAP70 (Ab-319) from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;WB:1:500-1:1000, IHC:1:50-1:200 |
|||
FOXO1 (Ab-319) Antibody |
|||
| CSB-PA953422- | Cusabio | each | EUR 402 |
|
Description: A polyclonal antibody against FOXO1 (Ab-319). Recognizes FOXO1 (Ab-319) from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;WB:1:500-1:1000, IHC:1:50-1:200 |
|||
FOXO1 (Ab-319) Antibody |
|||
| CSB-PA953422-100ul | Cusabio | 100ul | EUR 379.2 |
|
Description: A polyclonal antibody against FOXO1 (Ab-319). Recognizes FOXO1 (Ab-319) from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;WB:1:500-1:1000, IHC:1:50-1:200 |
|||
FKHR (Ab-319) Antibody |
|||
| E11-7086B | EnoGene | 100μg/100μl | EUR 225 |
|
Description: Available in various conjugation types. |
|||
MEF2A (Ab-319) Antibody |
|||
| E11-7145B | EnoGene | 100μg/100μl | EUR 225 |
|
Description: Available in various conjugation types. |
|||
MEF2A (Ab-319) Antibody |
|||
| E021040-1 | EnoGene | 50μg/50μl | EUR 100 |
|
Description: Available in various conjugation types. |
|||
MEF2A (Ab-319) Antibody |
|||
| E021040-2 | EnoGene | 100μg/100μl | EUR 170 |
|
Description: Available in various conjugation types. |
|||
FKHR (Ab-319) Antibody |
|||
| E021161-1 | EnoGene | 50μg/50μl | EUR 100 |
|
Description: Available in various conjugation types. |
|||
FKHR (Ab-319) Antibody |
|||
| E021161-2 | EnoGene | 100μg/100μl | EUR 170 |
|
Description: Available in various conjugation types. |
|||
SFXN1 (319) Mouse mAb |
|||
| MBS435114-002mL | MyBiosource | 0.02mL | EUR 270 |
SFXN1 (319) Mouse mAb |
|||
| MBS435114-005mL | MyBiosource | 0.05mL | EUR 415 |
SFXN1 (319) Mouse mAb |
|||
| MBS435114-01mL | MyBiosource | 0.1mL | EUR 660 |
SFXN1 (319) Mouse mAb |
|||
| MBS435114-5x01mL | MyBiosource | 5x0.1mL | EUR 2655 |
MEF2A (Ab-319) Antibody |
|||
| MBS7130368-01mL | MyBiosource | 0.1mL | EUR 270 |
MEF2A (Ab-319) Antibody |
|||
| MBS7130368-5x01mL | MyBiosource | 5x0.1mL | EUR 1200 |
Influenza HA (307-319) |
|||
| MBS5789455-INQUIRE | MyBiosource | INQUIRE | Ask for price |
FOXO1 (Ab-319) Antibody |
|||
| MBS7131946-01mL | MyBiosource | 0.1mL | EUR 270 |
FOXO1 (Ab-319) Antibody |
|||
| MBS7131946-5x01mL | MyBiosource | 5x0.1mL | EUR 1200 |
ZAP70 (Ab-319) Antibody |
|||
| MBS7131951-01mL | MyBiosource | 0.1mL | EUR 270 |
ZAP70 (Ab-319) Antibody |
|||
| MBS7131951-5x01mL | MyBiosource | 5x0.1mL | EUR 1200 |
Influenza HA (307-319) |
|||
| MBS8246673-10mg | MyBiosource | 10mg | EUR 600 |
Influenza HA (307-319) |
|||
| MBS8246673-1mg | MyBiosource | 1mg | EUR 235 |
Influenza HA (307-319) |
|||
| MBS8246673-5mg | MyBiosource | 5mg | EUR 430 |
Influenza HA (307-319) |
|||
| MBS8246673-5x10mg | MyBiosource | 5x10mg | EUR 2610 |
Beta-Amyloid (319-335) |
|||
| MBS8246183-10mg | MyBiosource | 10mg | EUR 625 |
Beta-Amyloid (319-335) |
|||
| MBS8246183-1mg | MyBiosource | 1mg | EUR 240 |
Beta-Amyloid (319-335) |
|||
| MBS8246183-5mg | MyBiosource | 5mg | EUR 445 |
Beta-Amyloid (319-335) |
|||
| MBS8246183-5x10mg | MyBiosource | 5x10mg | EUR 2730 |
FKHR (Ab-319) Antibody |
|||
| MBS858928-01mg | MyBiosource | 0.1mg | EUR 305 |
FKHR (Ab-319) Antibody |
|||
| MBS858928-01mLAF405L | MyBiosource | 0.1mL(AF405L) | EUR 465 |
FKHR (Ab-319) Antibody |
|||
| MBS858928-01mLAF405S | MyBiosource | 0.1mL(AF405S) | EUR 465 |
FKHR (Ab-319) Antibody |
|||
| MBS858928-01mLAF610 | MyBiosource | 0.1mL(AF610) | EUR 465 |
FKHR (Ab-319) Antibody |
|||
| MBS858928-01mLAF635 | MyBiosource | 0.1mL(AF635) | EUR 465 |
FKHR (Ab-319) Antibody |
|||
| MBS857715-005mg | MyBiosource | 0.05mg | EUR 190 |
FKHR (Ab-319) Antibody |
|||
| MBS857715-01mg | MyBiosource | 0.1mg | EUR 255 |
FKHR (Ab-319) Antibody |
|||
| MBS857715-01mLAF405M | MyBiosource | 0.1mL(AF405M) | EUR 465 |
FKHR (Ab-319) Antibody |
|||
| MBS857715-01mLAF546 | MyBiosource | 0.1mL(AF546) | EUR 465 |
FKHR (Ab-319) Antibody |
|||
| MBS857715-01mLAF750 | MyBiosource | 0.1mL(AF750) | EUR 465 |
MEF2A (Ab-319) Antibody |
|||
| MBS8510197-01mg | MyBiosource | 0.1mg | EUR 305 |
MEF2A (Ab-319) Antibody |
|||
| MBS8510197-01mLAF405L | MyBiosource | 0.1mL(AF405L) | EUR 465 |
MEF2A (Ab-319) Antibody |
|||
| MBS8510197-01mLAF405S | MyBiosource | 0.1mL(AF405S) | EUR 465 |
MEF2A (Ab-319) Antibody |
|||
| MBS8510197-01mLAF610 | MyBiosource | 0.1mL(AF610) | EUR 465 |
MEF2A (Ab-319) Antibody |
|||
| MBS8510197-01mLAF635 | MyBiosource | 0.1mL(AF635) | EUR 465 |
MEF2A (Ab-319) Antibody |
|||
| MBS856735-005mg | MyBiosource | 0.05mg | EUR 190 |
MEF2A (Ab-319) Antibody |
|||
| MBS856735-01mg | MyBiosource | 0.1mg | EUR 255 |
MEF2A (Ab-319) Antibody |
|||
| MBS856735-01mLAF405M | MyBiosource | 0.1mL(AF405M) | EUR 465 |
MEF2A (Ab-319) Antibody |
|||
| MBS856735-01mLAF546 | MyBiosource | 0.1mL(AF546) | EUR 465 |
MEF2A (Ab-319) Antibody |
|||
| MBS856735-01mLAF750 | MyBiosource | 0.1mL(AF750) | EUR 465 |
FKHR (Ab-319) Antibody |
|||
| MBS9412592-005mL | MyBiosource | 0.05mL | EUR 245 |
FKHR (Ab-319) Antibody |
|||
| MBS9412592-01mL | MyBiosource | 0.1mL | EUR 305 |
FKHR (Ab-319) Antibody |
|||
| MBS9412592-5x01mL | MyBiosource | 5x0.1mL | EUR 1230 |
MEF2A (Ab-319) Antibody |
|||
| MBS9408672-005mL | MyBiosource | 0.05mL | EUR 245 |
MEF2A (Ab-319) Antibody |
|||
| MBS9408672-01mL | MyBiosource | 0.1mL | EUR 305 |
MEF2A (Ab-319) Antibody |
|||
| MBS9408672-5x01mL | MyBiosource | 5x0.1mL | EUR 1230 |
Influenza HA (307-319) |
|||
| TP1854-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: Influenza HA (307-319) |
|||
Influenza HA (307-319) |
|||
| TP1854-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: Influenza HA (307-319) |
|||
Influenza HA (307-319) |
|||
| TP1854-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: Influenza HA (307-319) |
|||
Influenza HA (307-319) |
|||
| TP1854-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: Influenza HA (307-319) |
|||
Influenza HA (307-319) |
|||
| TP1854-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: Influenza HA (307-319) |
|||
anti-FOXO1A (Ab-319) |
|||
| LF-PA20163 | Abfrontier | 100 ul | EUR 400.8 |
|
Description: Rabbit polyclonal to FOXO1A |
|||
anti-MEF2A (Ab-319) |
|||
| LF-PA20283 | Abfrontier | 100 ul | EUR 400.8 |
|
Description: Rabbit polyclonal to MEF2A |
|||
anti-ZAP70 (Ab-319) |
|||
| LF-PA20528 | Abfrontier | 100 ul | EUR 400.8 |
|
Description: Rabbit polyclonal to ZAP70 |
|||
GPR-99 (319-337) (Human) |
|||
| 001-31 | PHOENIX PEPTIDE | 100 μg | EUR 177.12 |
GPR-8 (319-333) (Human) |
|||
| 001-57 | PHOENIX PEPTIDE | 100 μg | EUR 214.92 |
ZAP-70 (Ab-319) Antibody |
|||
| 8B7255 | AAT Bioquest | 50ug | EUR 368 |
|
Description: ZAP-70 (Ab-319) Antibody |
|||
Zap-70 (Ab-319) Antibody |
|||
| 21173 | SAB | 100ul | EUR 319 |
Zap-70 (Ab-319) Antibody |
|||
| 21173-100ul | SAB | 100ul | EUR 302.4 |
Zap-70 (Ab-319) Antibody |
|||
| 21173-50ul | SAB | 50ul | EUR 224.4 |
Polyclonal HSF1 Antibody (aa270-319) |
|||
| APR07827G | Leading Biology | 0.05ml | EUR 580.8 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human HSF1 (aa270-319). This antibody is tested and proven to work in the following applications: |
|||
Yeast Reductase (aa 1 - 319) |
|||
| DAG1754 | Creative Diagnostics | 500 ug | EUR 756 |
|
Description: Recombinant |
|||
Influenza HA (307 319) Peptide |
|||
| 20-abx266401 | Abbexa |
|
|
Influenza HA (307 319) Peptide |
|||
| abx266401-1ml | Abbexa | 1 ml | EUR 487.5 |
Influenza HA (307 319) Peptide |
|||
| abx266401-200l | Abbexa | 200 µl | EUR 337.5 |
Rabbit anti FKHR (Ab-319) |
|||
| AP21161 | Angio Proteomie | 100ul | EUR 307.2 |
Rabbit anti Zap70 (Ab-319) |
|||
| AP21173 | Angio Proteomie | 100ul | EUR 307.2 |
ZAP-70 (Ab-319) Antibody |
|||
| E11-7255B | EnoGene | 100μg | EUR 225 |
|
Description: Available in various conjugation types. |
|||
Zap-70 (Ab-319) Antibody |
|||
| E021173-1 | EnoGene | 50μg/50μl | EUR 100 |
|
Description: Available in various conjugation types. |
|||
Zap-70 (Ab-319) Antibody |
|||
| E021173-2 | EnoGene | 100μg/100μl | EUR 170 |
|
Description: Available in various conjugation types. |
|||
Anti-HIV1 Vif Antibody (319) |
|||
| MBS4160979-01mL | MyBiosource | 0.1mL | EUR 820 |
Anti-HIV1 Vif Antibody (319) |
|||
| MBS4160979-5x01mL | MyBiosource | 5x0.1mL | EUR 3430 |
Mouse Anti-HIV1 Vif [319] |
|||
| MBS375252-01mg | MyBiosource | 0.1mg | EUR 520 |
Mouse Anti-HIV1 Vif [319] |
|||
| MBS375252-5x01mg | MyBiosource | 5x0.1mg | EUR 2125 |
ZAP-70 (Ab-319) Antibody |
|||
| MBS858463-01mg | MyBiosource | 0.1mg | EUR 305 |
ZAP-70 (Ab-319) Antibody |
|||
| MBS858463-01mLAF405L | MyBiosource | 0.1mL(AF405L) | EUR 465 |
ZAP-70 (Ab-319) Antibody |
|||
| MBS858463-01mLAF405S | MyBiosource | 0.1mL(AF405S) | EUR 465 |
ZAP-70 (Ab-319) Antibody |
|||
| MBS858463-01mLAF610 | MyBiosource | 0.1mL(AF610) | EUR 465 |
ZAP-70 (Ab-319) Antibody |
|||
| MBS858463-01mLAF635 | MyBiosource | 0.1mL(AF635) | EUR 465 |
Zap-70 (Ab-319) Antibody |
|||
| MBS856963-005mg | MyBiosource | 0.05mg | EUR 190 |
Zap-70 (Ab-319) Antibody |
|||
| MBS856963-01mg | MyBiosource | 0.1mg | EUR 255 |
Zap-70 (Ab-319) Antibody |
|||
| MBS856963-01mLAF405M | MyBiosource | 0.1mL(AF405M) | EUR 465 |
Zap-70 (Ab-319) Antibody |
|||
| MBS856963-01mLAF546 | MyBiosource | 0.1mL(AF546) | EUR 465 |
Zap-70 (Ab-319) Antibody |
|||
| MBS856963-01mLAF750 | MyBiosource | 0.1mL(AF750) | EUR 465 |
Zap-70 (Ab-319) Antibody |
|||
| MBS9407499-005mL | MyBiosource | 0.05mL | EUR 245 |
Zap-70 (Ab-319) Antibody |
|||
| MBS9407499-01mL | MyBiosource | 0.1mL | EUR 305 |
Zap-70 (Ab-319) Antibody |
|||
| MBS9407499-5x01mL | MyBiosource | 5x0.1mL | EUR 1230 |
pcDNA3.1(+)-Flag-CTBP11(319-440AA) |
|||
| PPL00276-2e | Bioworld Biotech | 366bp | EUR 218 |
|
Description: pcDNA3.1(+) |
|||
CoV-2 S1 (319-541) |
|||
| sars-021 | ProSpec Tany | 2µg | EUR 60 |
|
Description: Recombinant Coronavirus 2019-nCoV Spike Glycoprotein-S1 Receptor Binding Domain (319-541 a.a.) |
|||
CoV-2 S1 (319-537) |
|||
| sars-038 | ProSpec Tany | 2µg | EUR 100 |
|
Description: Recombinant Coronavirus 2019-nCoV Spike Glycoprotein-S1 Receptor Binding Domain (319-537 a.a.) |
|||
CoV-2 S1 (319-529) |
|||
| sars-050 | ProSpec Tany | 2µg | EUR 60 |
|
Description: Recombinant Coronavirus 2019-nCoV Spike Glycoprotein-S1 Receptor Binding Domain (319-529 a.a.) |
|||
Anti-MEF2A (Ab-319) Antibody |
|||
| Y021040 | ABM | 100 µg | EUR 285 |
Anti-FKHR (Ab-319) Antibody |
|||
| Y021161 | ABM | 100 µg | EUR 285 |
Influenza HA (307-319) Peptide |
|||
| PE-53126 | Novatein Biosciences, Inc. |
|
|
GPR-41 (292-319) (Rat, Mouse) |
|||
| 001-98 | PHOENIX PEPTIDE | 100 μg | EUR 282.96 |
Anti-Zap-70 (Ab-319) Antibody |
|||
| A00754 | BosterBio | 100ul | EUR 360 |
|
Description: Boster Bio Anti-Zap-70 (Ab-319) Antibody (Catalog # A00754). Tested in WB, IHC applications. This antibody reacts with Human, Mouse, Rat. |
|||
Zinc Finger Protein 319 (ZNF319) Antibody |
|||
| abx030177-400l | Abbexa | 400 µl | EUR 518.75 |
Zinc Finger Protein 319 (ZNF319) Antibody |
|||
| abx030177-400ul | Abbexa | 400 ul | EUR 627.6 |
Zinc Finger Protein 319 (ZNF319) Antibody |
|||
| abx030177-80l | Abbexa | 80 µl | EUR 281.25 |
Zap-70 (Ab-319) Conjugated Antibody |
|||
| C21173 | SAB | 100ul | EUR 476.4 |
CDDO EA, RTA 405, tP 319 |
|||
| MBS130347-100mg | MyBiosource | 100mg | EUR 1065 |
CDDO EA, RTA 405, tP 319 |
|||
| MBS130347-500mg | MyBiosource | 500mg | EUR 2775 |
OAEC00390-50UG - MEF2A (Ab-319) Antibody |
|||
| OAEC00390-50UG | Aviva Systems Biology | 50ug | EUR 259 |
OAEC00506-50UG - FKHR (Ab-319) Antibody |
|||
| OAEC00506-50UG | Aviva Systems Biology | 50ug | EUR 259 |
Zap-70 (Ab-319) Conjugated Antibody |
|||
| MBS9438734-01mLAF350 | MyBiosource | 0.1mL(AF350) | EUR 480 |
Zap-70 (Ab-319) Conjugated Antibody |
|||
| MBS9438734-01mLAF405 | MyBiosource | 0.1mL(AF405) | EUR 480 |
Zap-70 (Ab-319) Conjugated Antibody |
|||
| MBS9438734-01mLAF488 | MyBiosource | 0.1mL(AF488) | EUR 480 |
Zap-70 (Ab-319) Conjugated Antibody |
|||
| MBS9438734-01mLAF555 | MyBiosource | 0.1mL(AF555) | EUR 480 |
Zap-70 (Ab-319) Conjugated Antibody |
|||
| MBS9438734-01mLBiotin | MyBiosource | 0.1mL(Biotin) | EUR 480 |
CoV-2 S1 (319-541), Fc |
|||
| sars-029 | ProSpec Tany | 2µg | EUR 100 |
|
Description: Recombinant Coronavirus 2019-nCoV Spike Glycoprotein-S1 Receptor Binding Domain (319-541 a.a.), Fc |
|||
It also diminished the release of dopamine, glutamate, and norepinephrine and increased the count of degenerated neurons. Alpha tocopherol treatment significantly attenuated the deleterious effects induced by pregabalin. The role of alpha tocopherol in ameliorating the oxidative stress injury, and apoptosis induced by pregabalin, along with its role in normalizing neurotransmitters, modulating the ERK/JNK/p38-MAPK signaling pathways and improving the histopathological cortical changes, offers alpha tocopherol as a promising adjunctive therapy in patients undergoing prolonged pregabalin therapy as those suffering from prolonged seizures and neuropathies.
